24 Apr 2019

CMS OUTLINES NEW PRIMARY CARE PAYMENT MODELS AIMED AT GREATER SHARED RISK APRIL 22

      The U.S. Centers for Medicare & Medicaid Services has proposed changes with several new primary care payment models, including one that would shift providers to global payments. The Trump Administration says it is building on the progress made over the last two years and further the CMS priority

0
23 Apr 2019

PELVIC VEIN OBSTRUCTION: VeinCare Centers of Tennessee now implant new BD Venovo stents to open pelvis vein

  VeinCare Centers of Tennessee is one of the first clinics in the United States to implant the new BD Venovo stent in obstructed pelvic veins. The Venovo stent is the first stent designed specifically for use in treating obstruction of veins to be approved by the Food and Drug

0
22 Apr 2019

AVLS Phlebology Primer will be June 1 in Atlanta

Phlebology Primer  The AVLS Phlebology Primer will be June 1 in Atlanta. Review the essentials of venous and lymphatic disease and care from experienced practitioners from several different primary disciplines. If you are new to vein and lymphatic care, this is a great overview. Topics covered include venous and lymphatic

0
22 Apr 2019

The AVLS NTNT Symposium will be June 1 in Atlanta

NTNT Symposium The NTNT Symposium will be June 1 in Atlanta. Non-thermal, non-tumescent ablation techniques have emerged as viable alternatives to more traditional options such as endovenous laser and radiofrequency ablation. Recent developments in reimbursement for these technologies make them even more appealing for clinicians treating venous disease.   The

0
22 Apr 2019

AVLS RECEIVING RESEARCH ABSTRACTS FOR 2019 ANNUAL CONGRESS EMERGING SCIENCE PROGRAM

           The American Vein & Lymphatic Society (AVLS) is accepting research abstracts for presentation at the AVLS 2019 Annual Congress. Access to emerging science in the medical field is essential for physicians to deepen clinical competence and improve their practice. The AVLS 2019 Annual Congress Emerging

0
13 Apr 2019

BiosupportMD dietary supplements as adjuncts in venous, lymphatic care*

  BiosupportMD is a nutraceutical company created by John Chuback, MD, FACS, RPVI, RVT, RPhS, and his business partners Christopher Tichio and Alexander von Summer in 2015. The company was the brainchild of Dr. Chuback, a board certified general and cardiovascular surgeon who has been specializing in the treatment of

0
13 Apr 2019

DABRA hits 94% success rate in treating PAD

Ra Medical Systems Inc. announced in early March study results that concluded DABRA Laser System achieved 94 percent success rates in patients with peripheral artery disease. Athar Ansari, MD, director of the California Heart & Vascular Clinic and principal in the study, said DABRA (Destruction of Arteriosclerotic Blockages by laser

0
13 Apr 2019

FDA issues ‘concerning signal’ on paclitaxel-coated devices

The FDA said in late March that its preliminary review of long-term follow-up data found a “potentially concerning signal” of increased long-term mortality in people with peripheral artery disease who were treated with paclitaxel-coated devices compared to those treated with bare devices. In a letter to healthcare providers, the FDA

0
13 Apr 2019

DABRA Excimer Laser Atherectomy to be Presented in Key Events at Charing Cross International Symposium

Ra Medical Systems Inc., headquartered in Carlsbad, California, has scheduled its key DABRA (Destruction of Arteriosclerotic Blockages by laser Radiation Ablation) Excimer Laser Atherectomy events at the upcoming Charing Cross International Symposium in London April 16–18. Ra Medical is in Booth No. 509. These events include case and podium presentations and

0
10 Apr 2019

CAN SOMEONE TELL ME WHAT A PBM REALLY DOES?

By Rachel Bluth   It was back-to-school day at the Senate Finance Committee hearing April 9. In the third of a series of hearings on rising drug prices, the senators seemed focused on getting an answer to one central question: What the heck is a pharmacy benefit manager? Pharmacy benefit managers,

0